Those prognosticator adjustments came a day after Integer published its latest earnings report, in which it posted ...

Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical ...

The Law Offices of Frank R. Cruz is investigating potential claims against the board of directors of Integer Holdings Corporation ("Integer" or the "Company") (NYSE: ITGR) concerning whether the board ...

Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of ...

Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...

Q4 2025 earnings call recap: results, 2026 guidance, product headwinds, margins, and buybacks—get key takeaways now.

A live webcast and replay for each event will be accessible under “News & Events” on the Investor Relations section of Integer’s website at investor.integer.net. Learn more about Integer at ...

Medical technology company Integer Holdings (NYSE:ITGR) reported in Q4 CY2025, with sales up 5% year on year to $472.1 million. The company expects the full year’s revenue to be around $1.85 billion, ...